Bellevue Group’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.6M | Buy |
2,441,830
+1,220,036
| +100% | +$38.3M | 1.69% | 16 |
|
|
2025
Q1 | $36.3M | Buy |
1,221,794
+16,330
| +1% | +$485K | 0.81% | 29 |
|
|
2024
Q4 | $35.6M | Hold |
1,205,464
| – | – | 0.68% | 33 |
|
|
2024
Q3 | $37.5M | Buy |
1,205,464
+50,810
| +4% | +$1.58M | 0.61% | 47 |
|
|
2024
Q2 | $39.1M | Buy |
1,154,654
+182,400
| +19% | +$6.18M | 0.64% | 48 |
|
|
2024
Q1 | $63.2M | Sell |
972,254
-3,800
| -0.4% | -$247K | 0.96% | 27 |
|
|
2023
Q4 | $66.7M | Buy |
976,054
+956,204
| +4,817% | +$65.3M | 1.02% | 29 |
|
|
2023
Q3 | $1.03M | Buy |
+19,850
| New | +$1.03M | 0.02% | 128 |
|